TRILLIUM THERAPEUTICS INC. Retained Earnings
TRILLIUM THERAPEUTICS INC. had Retained Earnings of -$297.95 million as of 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2021-11-12
- 2021-09-30: Retained Earnings (Accumulated Deficit) -$297.95M.
- 2021-06-30: Retained Earnings (Accumulated Deficit) -$278.64M.
- 2021-03-31: Retained Earnings (Accumulated Deficit) -$260.24M.
- 2020-12-31: Retained Earnings (Accumulated Deficit) -$249.38M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2021-09-30 | -$297.95M 10-Q · filed 2021-11-12 |
| 2021-06-30 | -$278.64M 10-Q · filed 2021-08-13 |
| 2021-03-31 | -$260.24M 10-Q · filed 2021-05-07 |
| 2020-12-31 | -$249.38M 10-Q · filed 2021-11-12 |
| 2019-12-31 | -$190.03M 10-K · filed 2021-03-18 |